The states hope to block a rule that is expected to allow 100,000 immigrants brought to the U.S. illegally as children to enroll next year in the federal Affordable Care Act’s health insurance.
Novo is vying with Indianapolis-based Lilly for supremacy in the pharmaceutical industry’s fastest-growing new business, obesity drugs. The market is expected to reach $130 billion by the end of the decade.
The Indiana All Payer Claims Database website is expected to provide transparency to health care costs and allow consumers to compare prices across multiple health systems.
MBX is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.
The two additions could help Arrive AI—a maker of smart mailboxes with security and temperature-control features—to gain more traction with municipalities and health care providers.
Meanwhile, health care systems continue to send thousands of Hoosiers to court over unpaid sums as small as $250.
Indiana University Health, one of the state’s largest hospital systems, saw patient volumes and revenue grow in the first six months of the year, but saw operating income fall as the costs of labor, supplies and drugs increased to meet higher demand for surgeries and patient care.
The recalls are tied to an ongoing outbreak of listeria poisoning that has killed two people and sickened nearly three dozen in 13 states, according to the U.S. Centers for Disease Control and Prevention.
The program aims to reduce the likelihood of future violence by engaging victims of gun violence and their families with long-term services and support.
Plaintiffs rejected a state motion to reinstate its authority to impose premium-like charges on Medicaid beneficiaries under the Healthy Indiana Plan, urging the court to reject the state’s arguments.
Victoza yielded mixed results in a mid-stage study of Alzheimer’s disease, failing to meet its primary goal while showing hints that larger trials of similar drugs may be successful.
The expansion projects in three central Indiana communities are part of a larger investment the company said it is making across the Midwest to senior living and assisted living services in Indiana, Kentucky, Michigan and Ohio.
The test isn’t a replacement for colonoscopies, but provides a noninvasive approach to screening.
Researchers reported Sunday that new blood tests were 91% accurate in detecting Alzheimer’s disease, far more accurate than a diagnosis from primary care doctors and specialists.
Despite the decrease, Community Health Network saw an increase in admissions, emergency visits, deliveries and physician outpatient visits during the first six months of 2024.
It was a mating dance that lasted more than three years. At the end, Eli Lilly and Co. wound up buying a Massachusetts-based biotech developing treatments for inflammatory bowel disease for $3.2 billion.
Shortages of brand-name drugs made by Novo and Eli Lilly and Co. have allowed pharmacies to make what are essentially copies, and telehealth companies like Hims are selling them to patients at a steep discount.
The Roche drug is a once-daily pill, compared to Lilly’s tirzepatide, sold under the brand names Mounjaro (for diabetes) and Zepbound (for obesity), which is a once-weekly shot.
The Indianapolis-based health insurance giant posted solid second-quarter results, but emerging pressure in Medicaid appeared to spook investors.
The expansion plan includes construction of a 100,000-square-foot building on its corporate campus and the addition of 100 jobs.
